Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Instil Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 40 | 43 | +3 |
| Shares | 5.24M | 5.25M | +14.1K (+0.3%) |
| Value | $100.0M | $91.2M | −$8.82M (−8.8%) |
New holders (9)
Institutions that held Instil Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Velan Capital Investment Management LP | 69,000 | $1.20M | 1.23% |
| Omers Administration Corp | 18,700 | $324.6K | 0.00% |
| Schonfeld Strategic Advisors LLC | 13,864 | $240.7K | 0.00% |
| Acadian Asset Management LLC | 13,490 | $233.0K | 0.00% |
| Susquehanna International Group, LLP | 10,511 | $182.5K | 0.00% |
| Quest Partners LLC | 5,397 | $93.7K | 0.01% |
| Pinpoint Asset Management Ltd | 5,094 | $88.4K | 0.02% |
| FMR LLC | 79 | $1.37K | 0.00% |
| Eq Wealth Advisors, LLC | 40 | $694 | 0.00% |
Sold out (6)
Institutions that held Instil Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Superstring Capital Management LP | 148,017 | $2.83M |
| 683 Capital Management, LLC | 34,557 | $659.7K |
| XTX Topco Ltd | 12,533 | $239.3K |
| Militia Capital Partners, LP | 416 | $7.94K |
| Royal Bank of Canada | 113 | $2.00K |
| R Squared Ltd | 20 | $382 |